Research Article
Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria
Table 1
Sociodemographic and HIV related characteristics of the study participants.
| | Variable | = 288 (%) |
| | Mean age (years) | 39.6 ± 8.9 | | Gender distribution | | | Female , % | 172 (59.7) | | Male , % | 116 (40.3) | | Known duration of HIV (months) | | | <12 | 92 (31.9) | | 12–36 | 114 (39.6) | | 37–60 | 46 (16.0) | | ≥61 | 36 (12.5) | | Median (IQR) | 22 (8.0–42.0) | | CD4 count (cells/mm3) | | | <200 | 82 (28.5) | | 201–500 | 170 (59.0) | | ≥500 | 36 (12.5) | | Viral load (copies/mL) | | | <200 | 143 (49.7) | | ≥200 | 145 (50.3) | | On HAART | | | Yes | 145 (50.3) | | No | 143 (49.7) | | Drug regimen | | | Stavudine based | 48/145 (33.1) | | Zidovudine based | 62/145 (42.8) | | Tenofovir based | 35/145 (24.1) | | Median (IQR) duration of HAART (months) | 29.0 (16.0–40.0) |
|
|
HAART: highly active antiretroviral therapy.
|
